Publisher
Springer International Publishing
Reference20 articles.
1. Appelman-Dijkstra NM, Papapoulos SE (2015) Modulating bone resorption and bone formation in opposite directions in the treatment of postmenopausal osteoporosis. Drugs 75(10):1049–1058
2. Appelman-Dijkstra NM, Papapoulos SE (2016) From disease to treatment: from rare skeletal disorders to treatments for osteoporosis. Endocrine 52:414–426
3. Appelman-Dijkstra N, Van Lierop A, Papapoulos S (1993) SOST-related sclerosing bone dysplasias. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH et al (eds) GeneReviews(®). University of Washington, Seattle. Copyright © 1993–2023, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved
4. Beighton P (1988) Sclerosteosis. J Med Genet 25(3):200
5. Beighton P, Durr L, Hamersma H (1976a) The clinical features of sclerosteosis. A review of the manifestations in twenty-five affected individuals. Ann Intern Med 84(4):393–397